BioXcel Therapeutics (BTAI) Interest Coverage Ratio (QoQ) (2019 - 2026)
Powered by 
Analysis
BioXcel Therapeutics (BTAI) Interest Coverage Ratio (QoQ) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn |
| 10 | BioXcel Therapeutics | 2.19 Mn | 2.19 Mn | 160,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.68% |
| Mar 31, 2026 | -4.12% |
| Dec 31, 2025 | 28.11% |
| Sep 30, 2025 | 13.34% |
| Jun 30, 2025 | -48.45% |
| Mar 31, 2025 | 2.81% |
| Dec 31, 2024 | 35.51% |
| Sep 30, 2024 | 13.68% |
| Jun 30, 2024 | 30.22% |
| Mar 31, 2024 | -15.78% |
| Dec 31, 2023 | 61.04% |
| Sep 30, 2023 | 7.66% |
| Jun 30, 2023 | -5.77% |
| Mar 31, 2023 | 16.06% |
| Dec 31, 2022 | -71.90% |
| Sep 30, 2022 | 53.94% |
| Jun 30, 2022 | 99.49% |
| Mar 31, 2022 | -3.26% |
| Dec 31, 2021 | -78.68% |
| Sep 30, 2021 | -41.24% |